Oligonucleotide therapy: An emerging focus area for drug delivery in chronic inflammatory respiratory diseases

M Mehta, D Tewari, G Gupta, R Awasthi, H Singh… - Chemico-biological …, 2019 - Elsevier
Oligonucleotide-based therapies are advanced novel interventions used in the management
of various respiratory diseases such as asthma and Chronic Obstructive Pulmonary Disease …

The potential of siRNA based drug delivery in respiratory disorders: Recent advances and progress

K Dua, R Wadhwa, G Singhvi, V Rapalli… - Drug development …, 2019 - Wiley Online Library
Lung diseases are the leading cause of mortality worldwide. The currently available
therapies are not sufficient, leading to the urgent need for new therapies with sustained anti …

A microRNA-21–mediated SATB1/S100A9/NF-κB axis promotes chronic obstructive pulmonary disease pathogenesis

RY Kim, KP Sunkara, KR Bracke, AG Jarnicki… - Science Translational …, 2021 - science.org
Chronic obstructive pulmonary disease (COPD) is the third leading cause of morbidity and
death worldwide. Inhalation of cigarette smoke (CS) is the major cause in developed …

Nanoparticles in cancer treatment: opportunities and obstacles

R Awasthi, A Roseblade, PM Hansbro… - Current drug …, 2018 - ingentaconnect.com
In the United States, the estimated number of new cancer cases in 2018 will be approx. 1.7
million. Historically, combination chemotherapy has been the primary choice of treatment …

Mechanisms and treatments for severe, steroid‐resistant allergic airway disease and asthma

PM Hansbro, RY Kim, MR Starkey… - Immunological …, 2017 - Wiley Online Library
Severe, steroid‐resistant asthma is clinically and economically important since affected
individuals do not respond to mainstay corticosteroid treatments for asthma. Patients with …

Nanoparticle delivery of microRNA-146a regulates mechanotransduction in lung macrophages and mitigates injury during mechanical ventilation

CM Bobba, Q Fei, V Shukla, H Lee, P Patel… - Nature …, 2021 - nature.com
Mechanical ventilation generates injurious forces that exacerbate lung injury. These forces
disrupt lung barrier integrity, trigger proinflammatory mediator release, and differentially …

Assessing the potential of liposomes loaded with curcumin as a therapeutic intervention in asthma

ZY Ng, JY Wong, J Panneerselvam… - Colloids and surfaces B …, 2018 - Elsevier
Curcumin a component of turmeric, which is derived from Curcuma longa is used as a
colouring agent and as a dietary spice for centuries. Extensive studies have been done on …

MicroRNAs as biomarker for breast cancer

T Aggarwal, R Wadhwa, R Gupta… - … Metabolic & Immune …, 2020 - ingentaconnect.com
Regardless of advances in detection and treatment, breast cancer affects about 1.5 million
women all over the world. Since the last decade, genome-wide association studies (GWAS) …

[HTML][HTML] MicroRNAs as biological regulators in skin disorders

G Singhvi, P Manchanda, VK Rapalli, SK Dubey… - Biomedicine & …, 2018 - Elsevier
Abstract microRNAs are being investigated as promising therapeutic targets and biomarkers
for different disease conditions. miRNAs serve as essential regulators of cell differentiation …

The role of miR-214 in cardiovascular diseases

Y Zhao, M Ponnusamy, L Zhang, Y Zhang, C Liu… - European journal of …, 2017 - Elsevier
Cardiovascular disease (CVD) is the leading cause of death throughout the world. The
increase in new patients every year leads to a demand for the identification of valid and …